Trade Iovance Biotherapeutics - IOVA CFD

Trading Conditions

• Type: CFD
• Spread: 0.07
• Long position overnight funding adjustment: -0.02149%
• Short position overnight funding adjustment: -0.00074%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 50.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 3.83
• Open: 3.77
• 1-Year Change: 6.8%
• Day's Range: 3.59 - 3.91

What is Iovance Biotherapeutics (IOVA)?

Iovance Biotherapeutics is a biotechnology company engaged in the development of novel cancer immunotherapies. The company specializes in adoptive cell therapy, particularly tumor-infiltrating lymphocyte (TIL) therapies, designed to harness the body's immune system to target and destroy cancer cells. Iovance's research focuses on treating various solid tumors, including melanoma, cervical, and head and neck cancers. The company conducts clinical trials to evaluate the safety and efficacy of its therapeutic candidates. Iovance operates within the biopharmaceutical industry, aiming to advance innovative treatments that address unmet medical needs in oncology.

Iovance Biotherapeutics Stock Price Today: Live Overview

The price today is shaped by ongoing price actions, as Iovance Biotherapeutics trades at $3.73. The range today spans from $3.58 to $3.92, with a daily change percentage of -4.9608%.

FAQ: Iovance Biotherapeutics (IOVA)

What is the current price of IOVA stock?

The stock price is currently $3.73.

Does IOVA pay dividends?

Iovance Biotherapeutics does not pay dividends.

Does IOVA have a formal corporate presence or regional headquarters in the UAE?

Iovance Biotherapeutics does not have an official office or subsidiary in the UAE and operates via partners or distributors.

What is IOVA best known for?

Iovance Biotherapeutics is most famous for its cancer immunotherapy treatments.

What assets are typically shown together with IOVA?

Commonly shown alongside IOVA: Krystal Biotech, Inc., GeoVax Labs, Inc., Madrigal Pharmaceuticals, Inc.